GH — Guardant Health, Inc.
—
Nasdaq ·
Health Care ·
Health Care Providers & Services ·
CIK 1576280 ·
Last close
$143.28
Market Cap
$19.38B
52W High
$191.05
52W Low
$74.55
ADV30
2,078,678
Next earnings
2026-11-05
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Sep 2026 | 360,975,000 | 236,153,000 | -132,765,000 | -124,362,000 | 1,885,642,000 | 1,026,848,000 | 2,161,544,000 |
| Jun 2026 | 334,978,000 | 219,029,000 | -129,118,000 | -120,142,000 | 1,912,294,000 | 1,053,469,000 | 2,135,161,000 |
| Mar 2026 | 301,665,000 | 196,746,000 | -121,350,000 | -112,075,000 | 1,915,291,000 | 989,291,000 | 2,096,364,000 |
| Dec 2025 | 281,266,000 | 181,774,000 | -120,805,000 | -128,494,000 | 2,013,659,000 | 378,203,000 | 2,112,966,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-185,187,000
Investing CF
$-118,526,000
Financing CF
$737,796,000
CapEx
$-55,537,000
Dividends Paid
—
Buybacks
$0
EPS Diluted TTM
$-3.49
As of
2026-11-08
Balance + Analyst (yfinance extras)
Retained Earnings
$-3,226,729,000
Inventory
$105,463,000
Receivables
$144,249,000
ST Investments
$0
EBIT TTM
$-449,654,000
Pretax Income TTM
$-454,470,000
Interest Exp TTM
$4,816,000
Analysts
25
Yahoo Snapshot (yfinance, live)
Total Revenue
$1,278,883,968
EBITDA
$-464,692,000
Free Cash Flow
$-60,536,124
Enterprise Value
$21,075,181,568
Total Cash
$1,026,848,000
Total Debt
$1,691,433,984
Shares Out
135,285,975
Trailing EPS
$-3.68
Book Value
$-2.05
ROE
—
ROA
-19.9%
Div Yield
0.00%
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 982,021,000 | -437,248,000 | -416,277,000 | 2,013,659,000 | 2,112,966,000 | -99,307,000 | -184,760,000 |
| Dec 2024 | 739,016,000 | -443,594,000 | -436,373,000 | 1,485,609,000 | 1,625,256,000 | -139,647,000 | -239,858,000 |
| Dec 2023 | 563,948,000 | -564,725,000 | -479,449,000 | 1,786,421,000 | 1,627,737,000 | 158,684,000 | -324,975,000 |
| Dec 2022 | 449,538,000 | -544,378,000 | -654,588,000 | 1,609,985,000 | 1,549,805,000 | 60,180,000 | -309,463,000 |
TTM Snapshot
Revenues TTM
$1,183,105,000
NetIncome TTM
$-453,436,000
OpCashFlow TTM
—
Assets (Latest)
$1,912,294,000
Forward EPS
$-0.41
Max Pain — expiry 2027-01-15
max pain strike: $160.00 · spot: $145.14 · call oi: 4,575 · put oi: 4,304
Expected Move to 2027-01-15:
±$25.30
(17.43%) —
implied range
$119.84 –
$170.44
· ATM straddle on $145.00 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| THC | TENET HEALTHCARE CORP | $22.45B | $282.07 | — |
| BTSG | BrightSpring Health Services, Inc. | $13.90B | $69.83 | — |
| EHC | Encompass Health Corp | $13.53B | $137.88 | — |
| DGX | QUEST DIAGNOSTICS INC | $28.29B | $256.35 | — |
| LH | LABCORP HOLDINGS INC. | $29.90B | $368.24 | — |
News headlines (Yahoo Finance, 1h cache)
Guardant Health Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2026-11-13 21:05 · Yahoo
Guardant Health Prices $500 Million Convertible Senior Notes Offering
2026-11-12 06:09 · Yahoo
Could You Have Seen The Run In Guardant Health Stock Coming?
2026-11-11 21:34 · Yahoo
Guardant Health Announces Proposed $500.0 Million Offering of Convertible Senior Notes Due 2032
2026-11-11 21:17 · Yahoo
Guardant Health Introduces New Epigenomic Applications Providing Deeper Insights for Treatment Selection with Guardant360® Liquid
2026-11-11 13:46 · Yahoo
Guardant360® Tissue Receives MOHW LDTS approval in Taiwan
2026-11-11 04:00 · Yahoo
PRECISION Study Published in ESMO Open Highlights Utility of Guardant360® Liquid and Guardant Reveal® to Assess Recurrence Risk After Surgery for Colorectal Cancer Metastases
2026-11-10 21:05 · Yahoo
Guardant Health to Participate in Upcoming Investor Conferences
2026-11-09 21:30 · Yahoo
GH Q3 2026 deep dive: new product launches and coverage wins drive growth, but market cautious on profitability
2026-11-09 10:05 · Yahoo
This cancer-testing stock is BTIG’s top pick after another major earnings beat
2026-11-09 02:38 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.